Compounds > betaxolol

betaxolol and bibw 2992

betaxolol has been researched along with bibw 2992 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsu, CK; Lu, CW; Yen, CF1

Other Studies

1 other study(ies) available for betaxolol and bibw 2992

ArticleYear
Topical betaxolol for treating relapsing paronychia with pyogenic granuloma-like lesions induced by epidermal growth factor receptor inhibitors.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:6

    Topics: Administration, Topical; Afatinib; Betaxolol; ErbB Receptors; Female; Follow-Up Studies; Granuloma, Pyogenic; Humans; Paronychia; Treatment Outcome

2018